Eliezer Brecher

D.M.D | Oral and Maxillofacial Surgeon



  
  16 E 52nd St, New York
  New York, 10022-5306

  212-696-0167    Maps & Directions
Eliezer Brecher is a New York, New York based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 16 E 52nd St, New York. Patients can reach him at 212-696-0167.
Eliezer Brecher deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Eliezer Brecher speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Eliezer Brecher
Specialization: Oral and Maxillofacial Surgeon
Gender:Male
Credentials: D.M.D
Accepts Medicare Assignment:May Accept
Practice Address:16 E 52nd St, New York,
New York, 10022-5306
Phone:212-696-0167
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8224302260
Enrollment ID: I20170914002804
NPI Number: 1134515786
NPI Enumeration Date: 10 Apr, 2015
NPI Last Update On: 23 Jul, 2019

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 6 Meadow Ln,
Lawrence, New York
Zip: 11559-1828
Phone Number: 516-984-7475
Patients can reach Eliezer Brecher at 16 E 52nd St, New York, New York or can call to book an appointment on 212-696-0167. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.

Comments/ Reviews: